Whistleblower Raises Concerns about Data Integrity and Research Protocols in Pfizer’s Clinical Trials
Right when the FDA approved vaccinations for children, a scathing report highlighting serious scientific misconduct arises.
A recent report from a whistleblower came out in the British Medical Journal, highlighting concerns over the protocols used by a contractor for Pfizer. The contractor, Vevantia Research Group, seems to have engaged in a plethora of misconduct when conducting these trials.
Take a look at a list of allegations (emphasis mine):
But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.
What’s so striking is that this isn’t the first time that issues concerning the clinical trials arose. When the FDA granted approval to Pfizer several months ago the BMJ released an opinion piece castigating the approval of the vaccine then.
Remember to take this information with a grain of salt, and hopefully the BMJ will provide more information about the evidence provided by the whistleblower.
Nonetheless it’s quite astonishing that now, after over a year of vaccinations, on the day that the FDA’s panel approves Pfizer’s vaccine for use in children age 5-11, did this information start to come out.
Not only do these revelations undermine the vaccines, it also undermines any credibility many of these institutions hope to cling onto. The FDA and the CDC have continued to assure the public about the safety of these vaccines, and any dissenting concerns or hesitations were immediately met with castigation.
Yet now we have information that doesn’t just indicate that there are concerns with these clinical trials, it indicates concerns that the FDA overlooked many of these issues! So how can an institution who expects us to hold it up with such high regard believe that any of this corruption is acceptable?
Unfortunately, it seems that no matter how much damage many of these institutions cause they seem to never be held accountable.
Take all of this information with a hint of skepticism and don’t use this to fully validate your opinion. However, this creates even more evidence that we should be demanding more transparency and more accountability for those who have dictated our behaviors and our ability to live and work over the past 19 months.
Maybe this information, in combination with children now being allowed to be vaccinated, may cause people to wake up and view things with some level of skepticism and hesitancy.
Thank you for reading my newsletter. If you enjoy my articles please consider becoming a free subscriber in order to receive notifications.
And share with others who may find these newsletters interesting.
Also, please consider becoming a paid member. The research and work put into these articles takes many hours and being a paid subscriber allows me to continue to do this full time.
Thacker, P.D. 2021. Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial. Taken from https://www.bmj.com/content/375/bmj.n2635
Doshi, P. 2021. Does the FDA think these data justify the first full approval of a covid-19 vaccine? Taken from https://blogs.bmj.com/bmj/2021/08/23/does-the-fda-think-these-data-justify-the-first-full-approval-of-a-covid-19-vaccine/